Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | April 27, 2018 | May 01, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date April 27, 2018 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,686 |
Reported balance
After 2018-04-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-04-27 · Grant · Acquired 1,127 · Balance 16,686 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. |
| Common StockSEC Table I · non-derivative | Direct | 16,426 |
Reported balance
After 2018-04-27 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-04-27 · Tax withholding · Disposed 260 · Balance 16,426 F2: These shares include 308 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program, as amended, and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
F2: These shares include 308 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program, as amended, and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2018 Filed May 1, 2018 22:28 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 260 | $175.37 | $45,596.20 |
DisclosureSEC source: 0001127602-18-015803 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,426 F2 · balance_after: These shares include 308 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program, as amended, and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2018 Filed May 1, 2018 22:28 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015803 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,686 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| November 08, 2017 Filed Nov 8, 2017 22:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,000 | $173.61 | $694,422.00 |
DisclosureSEC source: 0001127602-17-031636 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,528 F1 · price: $173.6055 is an average price. The prices ranged from $173.57 to $173.64 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include 277 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program, as amended, and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 01, 2017 Filed May 4, 2017 00:19 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 343 | $163.32 | $56,018.76 |
DisclosureSEC source: 0001127602-17-016729 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,498 F2 · balance_after: These shares include 247 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 01, 2017 Filed May 4, 2017 00:19 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016729 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,841 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001127602-16-062473 · form4.xml · derivative · entry 3 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:21 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,604 | $170.97 | $445,205.88 |
DisclosureSEC source: 0001127602-16-062473 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,567 F1 · balance_after: These shares include 203 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $71.64 | $358,200.00 |
DisclosureSEC source: 0001127602-16-062473 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2016 Filed May 5, 2016 23:52 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 307 | $158.99 | $48,809.93 |
DisclosureSEC source: 0001127602-16-051275 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,159 F1 · balance_after: These shares include 191 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 03, 2016 Filed May 5, 2016 23:52 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-051275 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,466 Read SEC document |
| August 31, 2015 Filed Sep 2, 2015 23:46 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $153.84 | $769,192.00 |
DisclosureSEC source: 0001127602-15-026495 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,150 F1 · price: $153.8384 is an average price. The prices ranged from $153.742341 to $153.997975 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include 154 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 24, 2015 Filed Apr 28, 2015 22:54 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 228 | $167.19 | $38,119.32 |
DisclosureSEC source: 0001127602-15-015449 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,139 F1 · balance_after: These shares include 143 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 24, 2015 Filed Apr 28, 2015 22:54 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-015449 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,367 Read SEC document |
| December 03, 2014 Filed Dec 3, 2014 22:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 507 | $166.75 | $84,540.37 |
DisclosureSEC source: 0001127602-14-034151 · form4.xml · nonDerivative · entry 3 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,159 F3 · price: $166.7463 is an average price. The prices ranged from $166.71 to $167.77 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F4 · balance_after: These shares include 126 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 03, 2014 Filed Dec 3, 2014 22:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 993 | $166.75 | $165,581.06 |
DisclosureSEC source: 0001127602-14-034151 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,666 F2 · price: $166.7483 is an average price. The prices ranged from $166.71 to $167.77 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| December 03, 2014 Filed Dec 3, 2014 22:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,500 | $169.28 | $253,920.00 |
DisclosureSEC source: 0001127602-14-034151 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,659 F1 · price: All shares were sold at $169.2800. Read SEC document |
| August 05, 2014 Filed Aug 7, 2014 20:17 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-14-024948 · form4.xml · derivative · entry 3 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2014 Filed Aug 7, 2014 20:17 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,471 | $128.65 | $317,894.15 |
DisclosureSEC source: 0001127602-14-024948 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149 F1 · balance_after: These shares include 116 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 05, 2014 Filed Aug 7, 2014 20:17 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $54.69 | $273,450.00 |
DisclosureSEC source: 0001127602-14-024948 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 21:12 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 539 | $113.72 | $61,295.08 |
DisclosureSEC source: 0001127602-14-015487 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,590 F2 · balance_after: These shares include 105 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 21:12 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-015487 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,148 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| March 06, 2014 Filed Mar 7, 2014 22:23 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-14-010746 · form4.xml · derivative · entry 6 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2014 Filed Mar 7, 2014 22:23 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-14-010746 · form4.xml · derivative · entry 5 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2014 Filed Mar 7, 2014 22:23 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $126.69 | $126,690.00 |
DisclosureSEC source: 0001127602-14-010746 · form4.xml · nonDerivative · entry 4 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,343 F1 · price: All shares were sold at $126.69. F2 · balance_after: These shares include 95 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 06, 2014 Filed Mar 7, 2014 22:23 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 6,021 | $126.19 | $759,789.99 |
DisclosureSEC source: 0001127602-14-010746 · form4.xml · nonDerivative · entry 3 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,343 Read SEC document |
| March 06, 2014 Filed Mar 7, 2014 22:23 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $50.44 | $252,200.00 |
DisclosureSEC source: 0001127602-14-010746 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2014 Filed Mar 7, 2014 22:23 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $58.43 | $292,150.00 |
DisclosureSEC source: 0001127602-14-010746 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2013 Filed May 2, 2013 22:26 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $54.74 | $0.00 |
DisclosureSEC source: 0001127602-13-015344 · form4.xml · derivative · entry 3 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2015-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2013 Filed May 2, 2013 22:26 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 6,593 | $106.67 | $703,275.31 |
DisclosureSEC source: 0001127602-13-015344 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,337 F1 · balance_after: These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 30, 2013 Filed May 2, 2013 22:26 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $54.74 | $547,400.00 |
DisclosureSEC source: 0001127602-13-015344 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:49 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 554 | $108.66 | $60,197.64 |
DisclosureSEC source: 0001127602-13-014795 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,930 F2 · balance_after: These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:49 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-014795 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,484 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| March 13, 2013 Filed Mar 14, 2013 22:18 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $54.74 | $0.00 |
DisclosureSEC source: 0001127602-13-010823 · form4.xml · derivative · entry 3 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2015-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2013 Filed Mar 14, 2013 22:18 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 7,177 | $91.75 | $658,489.75 |
DisclosureSEC source: 0001127602-13-010823 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,628 F1 · balance_after: These shares include 57 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 13, 2013 Filed Mar 14, 2013 22:18 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $54.74 | $547,400.00 |
DisclosureSEC source: 0001127602-13-010823 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2012 Filed May 29, 2012 22:16 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 419 | $68.38 | $28,651.22 |
DisclosureSEC source: 0001127602-12-018523 · form4.xml · nonDerivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,778 F1 · balance_after: These shares include 30 Dividend Equivalents ("DEs") granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 24, 2012 Filed May 29, 2012 22:16 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 549 | $68.38 | $37,540.62 |
DisclosureSEC source: 0001127602-12-018523 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,197 Read SEC document |
| April 27, 2012 Filed May 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $71.64 Strike: $71.64 | $358,200.00 |
DisclosureSEC source: 0001127602-12-015219 · form4.xml · derivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2022-04-27 Read SEC document |
| April 27, 2012 Filed May 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015219 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,746 F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 30 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 08, 2011 Filed Dec 12, 2011 23:55 UTC | AMGEN INC AMGN · Entity 2832 | GrantDividend Equivalent · Derivative | 9.55 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031944 · form4.xml · derivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19.5836 Underlying: Common Stock · 9.55 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:21 UTC | AMGEN INC AMGN · Entity 2832 | GrantDividend Equivalent · Derivative | 10.0336 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025061 · form4.xml · derivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10.0336 Underlying: Common Stock · 10.0336 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 04, 2011 Filed Aug 8, 2011 21:21 UTC | AMGEN INC AMGN · Entity 2832 | PurchaseCommon Stock | 1,000 | $53.02 | $53,019.50 |
DisclosureSEC source: 0001127602-11-023000 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,321 F1 · price: The price reported is an average price. The prices ranged from $53.005 to $53.03 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: Includes 1,828 Restricted Stock Units ("RSUs") which fully vest on April 25, 2012. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 00:49 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $54.69 Strike: $54.69 | $273,450.00 |
DisclosureSEC source: 0001127602-11-013872 · form4.xml · derivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2021-04-25 Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 00:49 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013872 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,321 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 22:58 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $58.43 Strike: $58.43 | $292,150.00 |
DisclosureSEC source: 0001127602-10-012367 · form4.xml · derivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-04-26 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 22:58 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012367 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,493 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| November 18, 2009 Filed Nov 18, 2009 21:28 UTC | AMGEN INC AMGN · Entity 2832 | PurchaseCommon Stock | 800 | $56.14 | $44,912.00 |
DisclosureSEC source: 0001127602-09-022879 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,782 F1 · balance_after: Includes 1,982 restricted stock units ("RSUs") which vests on April 28, 2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwsie deferred by the reporting person. Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 20:53 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-09-010125 · form4.xml · derivative · entry 2 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2016-04-28 Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 20:53 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010125 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,982 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous services as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| October 27, 2008 Filed Oct 29, 2008 15:26 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 16,000 | $54.74 Strike: $54.74 | $875,840.00 |
DisclosureSEC source: 0001181431-08-058564 · rrd221767.xml · derivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2015-10-27 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.